Cargando…
Lentinan enhances the antitumor effects of Delta-like 1 via neutrophils
BACKGROUND: Selective activation of Delta-like 1 (DLL1)-Notch signaling is a new approach to activate CD8(+) T cell and suppress tumor growth, while the efficacy remains modest. Lentinan (LNT) is a clinically used immunomodulation agent. Thus, we hypothesized that LNT could improve the efficacy of D...
Autores principales: | Xu, Haiyan, Qi, Ziwei, Zhao, Qi, Xue, Jiao, Zhu, Jiaxing, He, Yan, Liu, Guirong, Qin, Songbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414423/ https://www.ncbi.nlm.nih.gov/pubmed/36008793 http://dx.doi.org/10.1186/s12885-022-10011-w |
Ejemplares similares
-
Prognostic value of absolute lymphocyte count in patients with advanced esophageal cancer treated with immunotherapy: a retrospective analysis
por: Zhao, Qi, et al.
Publicado: (2022) -
Lentinan administration alleviates diarrhea of rotavirus-infected weaned pigs via regulating intestinal immunity
por: Fan, Xiangqi, et al.
Publicado: (2021) -
The Use of Lentinan for Treating Gastric Cancer
por: Ina, Kenji, et al.
Publicado: (2013) -
Protective Effects of Lentinan Against Lipopolysaccharide-Induced Mastitis in Mice
por: Yin, Huifang, et al.
Publicado: (2021) -
Lentinan Combined with (125)I Brachytherapy for Recurrent Ovarian Cancer
por: Jiang, Qin, et al.
Publicado: (2021)